StonvexLoading…
StonvexStonvexStonvexCore line items from RL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-03-29 | Annual 2024 2024-03-30 | Annual 2023 2023-04-01 | Annual 2022 2022-04-02 |
|---|---|---|---|---|
Revenue | $7.08B | $6.63B | $6.44B | $6.22B |
Operating Income | $932.10M | $756.40M | $704.20M | $798.40M |
Net Income | $742.90M | $646.30M | $522.70M | $600.10M |
EPS (Diluted) | $11.61 | $9.71 | $7.58 | $8.07 |
Total Assets | $7.05B | $6.60B | $6.79B | $7.72B |
Total Liabilities | $4.46B | $4.15B | $4.36B | $5.19B |
Cash & Equivalents | $1.92B | $1.66B | $1.53B | $1.86B |
Free Cash Flow OCF − CapEx | $1.02B | $904.90M | $193.50M | $549.00M |
Shares Outstanding | 64.00M | 66.50M | 69.00M | 74.30M |